Cargando…
Celastrol attenuates arterial and valvular calcification via inhibiting BMP2/Smad1/5 signalling
Vascular calcification is an important risk factor for the mortality and morbidity in chronic kidney disease (CKD). Unfortunately, until now there is no certain medication targeting vascular calcification in CKD. In this study, we explored the inhibitory effect of celastrol on high calcium–induced v...
Autores principales: | Su, Zhongping, Zong, Pengyu, Chen, Ji, Yang, Shuo, Shen, Yihui, Lu, Yan, Yang, Chuanxi, Kong, Xiangqing, Sheng, Yanhui, Sun, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686965/ https://www.ncbi.nlm.nih.gov/pubmed/32954678 http://dx.doi.org/10.1111/jcmm.15779 |
Ejemplares similares
-
Celastrol Alleviates Aortic Valve Calcification Via Inhibition of NADPH Oxidase 2 in Valvular Interstitial Cells
por: Liu, Huibing, et al.
Publicado: (2019) -
Inhibition of acetylation of histones 3 and 4 attenuates aortic valve calcification
por: Gu, Jia, et al.
Publicado: (2019) -
Influences of Sex and Estrogen in Arterial and Valvular Calcification
por: Zhang, Bin, et al.
Publicado: (2019) -
The predictive value of arterial and valvular calcification for mortality and cardiovascular events
por: Nicoll, Rachel, et al.
Publicado: (2014) -
Piperlongumine Attenuates High Calcium/Phosphate-Induced Arterial Calcification by Preserving P53/PTEN Signaling
por: Shi, Wenxiang, et al.
Publicado: (2021)